| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 5582175 | International Journal of Obstetric Anesthesia | 2017 | 26 Pages | 
Abstract
												A thromboprophylactic dose of tinzaparin 4500 IU had little detectable effect on coagulation as assessed by TEG and anti-Xa assay. These findings support consensus guidelines which state that it is acceptable to perform neuraxial blockade or remove an epidural catheter 10-12 h after a thromboprophylactic dose of tinzaparin. Rather than suggesting a lack of anticoagulant activity, the findings indicate that TEG may not have the sensitivity to detect a tinzaparin effect when this dose is used in this patient group.
											Related Topics
												
													Health Sciences
													Medicine and Dentistry
													Anesthesiology and Pain Medicine
												
											Authors
												S. Griffiths, C. Woo, V. Mansoubi, A. Riccoboni, A. Sabharwal, S. Napier, M. Columb, M. Laffan, G. Stocks, 
											